New Data and Clinical Context: An Update on Renal Cell Carcinoma Care Published 2021-06-21 Download video MP4 360p Download video MP4 720p Recommendations 56:10 5.24.2021 Urology COViD Didactics - Genetic Basis of Kidney Cancer 06:40 A Good Problem to Have | Renal Cell Carcinoma: The New Challenge | MedscapeTV 1:38:56 Watch Dr. Liu discuss #NSCLC updates from #ASCO24 - https://bit.ly/2024BiomarkersY 41:22 Striking Back at ALL With Antibody Regimens 22:38 Von Hippel-Lindau Disease: Clinical Update and New Drug Therapy 03:05 Immunotherapy Cancer Treatment: What is Pseudoprogression? 14:46 Excess Deaths at Night - Obstructive Sleep Apnea Explained Clearly 48:02 Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable NSCLC 1:40:03 #BreastCancer updates from #ASCO24 led by Dr. Jhaveri - https://bit.ly/2024MBCY 03:28 MK-6482 to Treat Renal Cell Carcinoma in Von Hippel-Lindau Disease Patients 1:01:33 Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Cancer 1:16:38 Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices 06:58 Liquid biopsy: Introduction to ctDNA 24:07 Sjogren's Syndrome Affects the Brain and Spine 02:15 MK-6482 Shows Promise in von Hippel-Lindau Disease-Associated Renal Cell Carcinoma 11:07 Mayo Clinic Q&A podcast: Liquid biopsy can help guide cancer treatment 1:38:05 #NSCLC updates from #ONS2024 - https://bit.ly/NSCLC24Y 43:58 Jon Fox's Trajectory Was Changed by a Second Opinion - It Takes Balls 59:06 Treatment Advances and Individualized Therapeutic Strategies in Prostate Cancer 03:07 How does CAR T cell therapy work? Similar videos 55:12 Selecting and Sequencing Targeted and Immunotherapy Regimens for Patients With RCC 06:44 Clinical insights into renal cell carcinoma trials | Nazli Dizman 03:13 Renal Cell Carcinoma: Early Management Strategies 05:58 CheckMate 9ER update confirms benefits of nivolumab–cabozantinib in RCC | Cristina Suárez 03:43 ASCO: New Data on Biomarkers in Renal Cell Carcinoma 05:34 Nephrectomy after complete response to immune checkpoint inhibitors for mRCC 27:59 Outcomes for patients with locally advanced renal cell carcinoma Christopher G. Wood, M.D., UT 56:36 Public Lecture: Immunotherapy & Cancer - The latest research 3:17:09 SOGO Masterclass - Renal Cell Carcinoma – Kidney and Beyond 47:21 Critical Advances in Immunotherapy for Kidney Cancer, with Nizar Tannir 09:50 Choosing Frontline Therapy for Metastatic Kidney Cancer 02:21 PRISM: importance of investigating the scheduling of treatment regimens for RCC 1:42:57 Live Webinar on Management of renal cell carcinoma in the new millennium 20:02 Management of Differentiated Thyroid Carcinoma in the Era of Targeted Therapy 1:00:53 Renal Cell Cancer: Indian Context, Diagnosis & Treatment 57:00 Current Approaches for Addressing Medical Financial Hardship in the Context of Cancer Care Delivery 01:11 Impact of the TME on CAR T-cell therapy for kidney cancer 1:06:48 Yale Center for Immuno-Oncology 32:46 Lenvatinib Pembrolizumab in RCC, the CLEAR trial with Karine Tawagi More results